“The U.S. has tested fewer than 6,000 samples from Americans suspected of the coronavirus infection, the top drug regulator acknowledged, as federal health officials struggled to explain the government’s difficulty creating a diagnostic tool to contain the disease,” Bloomberg reports.

Save to Favorites
